Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Abbasi

Showing results (281-290 of 303) with videos related to

Pageof 31
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndromeAli Abbasi, Eva Corpeleijn, Douwe Postmus, et al.
Diabetologia|June 5, 2014
Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) studyAli Abbasi, Eva Corpeleijn, Ron T Gansevoort, et al.
Clinical Chemistry|January 8, 2017
Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND StudyAli Abbasi, Lyanne M Kieneker, Eva Corpeleijn, et al.
Journal of Nanoscience and Nanotechnology|January 27, 2021
Tin as an Effective Doping Agent into ZnO for the Improved Photodegradation of Rhodamine BAqeel Ahmed Shah, Muhammad Ali Bhatti, Ali Dad Chandio, et al.
Diabetes|November 5, 2014
Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization studyAli Abbasi, Petronella E Deetman, Eva Corpeleijn, et al.
JAMA Ophthalmology|July 11, 2024
Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune DiseaseJoelle A Hallak, Ali Abbasi, Roger A Goldberg, et al.
Frontiers in Microbiology|December 15, 2023
Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenalUmar Saeed, Rawal Alies Insaf, Zahra Zahid Piracha, et al.
BMJ (Clinical Research Ed.)|September 20, 2012
Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation studyAli Abbasi, Linda M Peelen, Eva Corpeleijn, et al.
The New England Journal of Medicine|October 22, 2025
Common Diseases in Clinical Cohorts - Not Always What They SeemFedik Rahimov, Benjamin M Jacobs, John S Lee, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|March 7, 2018
Blood Eosinophil Count and Metabolic, Cardiac and Pulmonary Outcomes: A Mendelian Randomization StudyMarzyeh Amini, Judith M Vonk, Ali Abbasi, et al.
Pageof 31

Showing results (281-290 of 303) with videos related to

Sort By:
Pageof 31
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndromeAli Abbasi, Eva Corpeleijn, Douwe Postmus, et al.
Diabetologia|June 5, 2014
Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) studyAli Abbasi, Eva Corpeleijn, Ron T Gansevoort, et al.
Clinical Chemistry|January 8, 2017
Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND StudyAli Abbasi, Lyanne M Kieneker, Eva Corpeleijn, et al.
Journal of Nanoscience and Nanotechnology|January 27, 2021
Tin as an Effective Doping Agent into ZnO for the Improved Photodegradation of Rhodamine BAqeel Ahmed Shah, Muhammad Ali Bhatti, Ali Dad Chandio, et al.
Diabetes|November 5, 2014
Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization studyAli Abbasi, Petronella E Deetman, Eva Corpeleijn, et al.
JAMA Ophthalmology|July 11, 2024
Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune DiseaseJoelle A Hallak, Ali Abbasi, Roger A Goldberg, et al.
Frontiers in Microbiology|December 15, 2023
Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenalUmar Saeed, Rawal Alies Insaf, Zahra Zahid Piracha, et al.
BMJ (Clinical Research Ed.)|September 20, 2012
Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation studyAli Abbasi, Linda M Peelen, Eva Corpeleijn, et al.
The New England Journal of Medicine|October 22, 2025
Common Diseases in Clinical Cohorts - Not Always What They SeemFedik Rahimov, Benjamin M Jacobs, John S Lee, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|March 7, 2018
Blood Eosinophil Count and Metabolic, Cardiac and Pulmonary Outcomes: A Mendelian Randomization StudyMarzyeh Amini, Judith M Vonk, Ali Abbasi, et al.
Pageof 31